FinTrust Capital Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$29K Hold
2024
Q2
$17K Hold
2024
Q1
$20.4K Buy